Barclays on Health Care Facilities: Perspectives on Medicare Reimbursement for Molecular Diagnostic Testing
Go back to Barclays on Health Care Facilities: Perspectives on Medicare Reimbursement for Molecular Diagnostic Testing| Quest Diagnostics (NYSE: DGX) | Delayed: 243.87 -0.52 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $244.39 | 52 Week High | $86.85 | |||
| Open | $243.97 | 52 Week Low | $59.66 | |||
| Day High | $246.00 | P/E | 45.93 | |||
| Day Low | $242.46 | EPS | $5.31 | |||
| Volume | 837,736 | |||||
| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 339.34 +3.00 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $336.34 | 52 Week High | $141.32 | |||
| Open | $335.99 | 52 Week Low | $97.79 | |||
| Day High | $339.76 | P/E | 54.29 | |||
| Day Low | $334.40 | EPS | $6.25 | |||
| Volume | 466,310 | |||||
